Home » Newsletters » BioWorld

BioWorld

Oct. 5, 2000

View Archived Issues

Zarix Raises $23.5M In Series C For Phase III Pivotal Of Thymitaq

Appointments And Advancements

Other News To Note

MethylGene Raises $18.6M For Drug Discovery, Development

Neurocrine Seeks $115M Publicly Through Offering Of 3M Shares

Id Gene, Key Co-Conspirator Of Neuroblastoma - With Rb, Myc - Yields To Prospective Inhibitor

Isis Decides To Move 2302 Into Phase III After Revisiting Data